Aligning with California’s science standards, this session equips teachers to share life-saving information about genetic mutations, risks, and practical applications. Discover the science behind sickle cell trait, learn about prevalence and early detection, and explore innovative teaching strategies to raise awareness and empower students to make informed choices for their health. Together, let’s create a healthier future through genetic education.
The Road to FDA Approval: SCA-CRISPR
Presented by: Mark Okuda
Afternoon Session: 1 P.M. - 4 P.M.
On 12/8/2023, the FDA approved the use of CRISPR for treating sickle cell disease in the United States. This workshop will explain how the CRISPR gene-editing tool was engineered to mitigate this disorder.